The March 2026 GLP‑1 Telehealth Reset: From Compounding Arbitrage to Manufacturer‑Controlled Distribution
The industry’s proclaimed “affordability” narrative masks a regulatory and supply‑chain shift that is rewriting the economics of GLP‑1 delivery.
Read More
